Rovista Tablet 5mg, 10mg and 20mg (Rosuvastatin)

Getz Pharma (Pvt) LtdDRAP reg. 044044

Prescription required

Getz Pharma’s Pakistani leaflets say Rovista and Rovista EZ are to be sold on prescription only, so we dispense them on prescription.

In stock

5mg, 30 tabletsPrice confirmed on WhatsApp10mg, 30 tabletsPrice confirmed on WhatsApp20mg, 30 tabletsPrice confirmed on WhatsApp

Order 5mg, 30 tablets on WhatsApp

Same day or next day in Karachi, Lahore, Islamabad, Rawalpindi for orders confirmed before 6pm. Tracked courier, 2 to 4 working days everywhere else. Delivery Rs 250 in Rawalpindi and Islamabad, Rs 300 everywhere else, cash on delivery. Delivery details

Prices in PKR, checked 23 October 2026.

What Rovista is

Rovista (rosuvastatin 5, 10 or 20 mg) is a statin that lowers LDL (“bad”) cholesterol and triglycerides and raises HDL (“good”) cholesterol, used alongside diet for high cholesterol, and to prevent major cardiovascular events in people at high risk of a first one, according to Getz Pharma’s Pakistani leaflet for Rovista. The leaflet says it is to be sold on prescription only, so we dispense it on prescription.

Rovista 10 mg is DRAP reg. 044044 (DRAP registry entry), 5 mg is DRAP reg. 044043 and 20 mg DRAP reg. 044045. DRAP’s registry lists Rovista only as 5 mg, 10 mg and 20 mg tablets; we found no Rovista 40 mg registration.
Made in Karachi by Getz Pharma, to whom DRAP’s letters on the registration are addressed.
Report unexplained muscle pain, weakness or cramps straight away, especially with fever or feeling unwell: the UK product information for Crestor (AstraZeneca) asks patients to do so. Rarely, statins cause serious muscle damage.
Not in pregnancy or breastfeeding: Getz’s leaflet lists pregnancy, breastfeeding and women who could become pregnant and are not using contraception as reasons not to take it.
Rovista EZ is a different product: rosuvastatin combined with ezetimibe. It is described below and sold on this page as its own packs.
DRAP’s price index has no entry for Rovista.

What is in each tablet

One active ingredient, rosuvastatin (as rosuvastatin calcium), from the label claims in DRAP’s registry.

Active ingredient in each Rovista strength, with DRAP registration
Tablet	Ingredient	Amount per tablet
Rovista 5mg (DRAP reg. 044043)	Ingredient: Rosuvastatin (as calcium)	Amount per tablet: 5 mg
Rovista 10mg (DRAP reg. 044044)	Ingredient: Rosuvastatin (as calcium)	Amount per tablet: 10 mg
Rovista 20mg (DRAP reg. 044045)	Ingredient: Rosuvastatin (as calcium)	Amount per tablet: 20 mg

What it is used for

Lowering cholesterol and cardiovascular risk. Getz’s leaflet lists more uses than the UK label.

Uses of rosuvastatin, by label
Label	Uses
Pakistan, Getz leaflet	With diet: high cholesterol and mixed dyslipidaemia in adults; inherited high cholesterol (heterozygous familial hypercholesterolaemia) in adolescents aged 10 to 17; high triglycerides; type III hyperlipoproteinaemia; and slowing the progression of atherosclerosis. Also homozygous familial hypercholesterolaemia in adults, with other lipid-lowering treatment or alone; and preventing major cardiovascular events in people at high risk of a first one, alongside correcting other risk factors.
UK, Crestor	High cholesterol and mixed dyslipidaemia, and homozygous familial hypercholesterolaemia, in adults and children aged 6 and older, with diet; and preventing major cardiovascular events in people at high risk of a first one.
US, Crestor	Reducing the risk of heart attack, stroke and cardiovascular death in adults at increased risk; lowering LDL cholesterol with diet and exercise, including slowing atherosclerosis; high triglycerides; and primary dysbetalipoproteinaemia.

How to take it

Once a day, at any time of day, with or without food, according to Getz Pharma’s Pakistani leaflet for Rovista; your doctor sets the strength.

People of Asian ancestry can have higher blood levels of rosuvastatin: Getz’s leaflet says levels are about twice as high in Asian patients as in white patients, and recommends a lower starting dose for them. The UK label gives a smaller rise, about 1.3-fold, for Asian-Indians. Your doctor takes this into account.
Blood tests: the leaflet says cholesterol levels should be checked within 2 to 4 weeks, and liver tests done before starting, 12 weeks after starting or after any dose increase, and periodically after that.
Antacids containing aluminium and magnesium hydroxide: the leaflet says to take the antacid at least 2 hours after Rovista, because taken together it halves the level of rosuvastatin.
Keep to the diet your doctor recommends: the labels give rosuvastatin as an addition to diet, not a replacement.

Muscle, nerve, lung and blood sugar warnings

Statins are usually well tolerated, but a few effects need attention.

Myasthenia gravis: DRAP’s 2024 safety alert on statins tells patients to inform their doctor before starting if they have myasthenia gravis, to talk to their doctor about arm or leg weakness that worsens with activity, double vision, drooping eyelids, difficulty swallowing or shortness of breath, and to seek help immediately for severe breathing or swallowing problems.
The same DRAP alert advises patients not to stop their statin without first discussing it with their doctor. Getz’s leaflet as published online does not yet include this warning, which DRAP required of all statin makers.
Lung problems: the UK label says exceptional cases of interstitial lung disease have been reported with some statins, especially with long-term therapy, and that statin treatment should be stopped if lung disease is suspected.
Blood sugar: Getz’s leaflet says statins, including rosuvastatin, raise HbA1c and fasting glucose. The UK label says the risk of diabetes is outweighed by the reduction in vascular risk and is not a reason to stop.
Severe skin reactions: the UK label says Stevens-Johnson syndrome and DRESS, which can be life-threatening, have been reported with rosuvastatin. Get medical help at once for a widespread rash with blisters or fever.

Who should not take it, or should ask a doctor first

From Getz Pharma’s Pakistani leaflet for Rovista unless another label is named.

Must not take it: anyone allergic to rosuvastatin; active liver disease or unexplained, persistent raised liver enzymes; severe kidney disease; muscle disease (myopathy); anyone taking ciclosporin or, for HIV, protease inhibitors; and children under 10.
Ask a doctor first: kidney problems, an underactive thyroid, a personal or family history of muscle disorders, past muscle problems with another statin or a fibrate, heavy alcohol use or liver disease, age over 70, or taking a fibrate.
Lactose: the UK Crestor tablets contain lactose. We haven’t seen Rovista’s ingredient list, so ask our pharmacist if you have a rare lactose intolerance.

Other medicines

Several medicines raise rosuvastatin levels and the risk of muscle damage. Tell your doctor about everything you take.

Medicines that interact with rosuvastatin, with source
Medicine	What the source says	Source
Ciclosporin	What the source says: Must not be combined: Getz’s leaflet and the UK label list it as a contraindication; the UK label says rosuvastatin levels were on average 7 times higher.	Source: Leaflet; UK, 4.5
Fusidic acid (an antibiotic) by mouth or injection	What the source says: Must not be taken with rosuvastatin, or within 7 days of stopping fusidic acid.	Source: UK, 4.4
HIV protease inhibitors; the hepatitis C combination sofosbuvir/velpatasvir/voxilaprevir	What the source says: Getz’s leaflet contraindicates protease inhibitors; the UK label contraindicates sofosbuvir/velpatasvir/voxilaprevir and does not recommend certain protease inhibitors unless the dose is adjusted.	Source: Leaflet; UK, 4.3–4.5
Gemfibrozil and other fibrates; niacin	What the source says: Gemfibrozil significantly raises rosuvastatin levels and the combination should be avoided; niacin may increase the risk of muscle effects.	Source: Leaflet
Warfarin and other coumarin blood thinners	What the source says: INR should be checked before starting rosuvastatin and often during early treatment.	Source: Leaflet
Ticagrelor, darolutamide	What the source says: They raise rosuvastatin levels.	Source: UK, 4.5
Aluminium and magnesium hydroxide antacids	What the source says: Take the antacid at least 2 hours after rosuvastatin.	Source: Leaflet

Pregnancy and breastfeeding

Getz’s Pakistani leaflet rules it out in pregnancy and breastfeeding; the UK and US labels say stop it once pregnancy is recognised.

Rosuvastatin in pregnancy and breastfeeding, by label
Label	What it says
Pakistan, Getz leaflet	Contraindicated during pregnancy and breastfeeding, and in women who could become pregnant and are not using appropriate contraception.
UK, Crestor	Not recommended in pregnancy; stop as soon as pregnancy is recognised, though for people at very high cardiovascular risk the ongoing need should be weighed. Breastfeeding is not recommended.
US, Crestor	May cause fetal harm; stop when pregnancy is recognised, or consider the patient’s ongoing needs. Breastfeeding is not recommended.

Side effects

Getz’s leaflet says rosuvastatin is generally well tolerated and side effects are usually mild and short-lived.

Side effects of rosuvastatin, from Getz’s leaflet and the UK label
How often	Side effects
Common (leaflet)	Headache, dizziness, constipation, nausea, abdominal pain, muscle pain, weakness, diabetes.
Uncommon (leaflet)	Itching, rash, hives.
Rare (leaflet)	Allergic reactions including swelling under the skin (angioedema); muscle disease and serious muscle breakdown (rhabdomyolysis); pancreatitis.
Very rare or not known (UK)	Jaundice, hepatitis, memory loss, nerve damage, joint pain, blood in the urine; depression, sleep problems, cough, breathlessness, myasthenia gravis, tendon problems.

Driving: the UK label says rosuvastatin is unlikely to affect driving, but dizziness may occur.

Rovista EZ: rosuvastatin with ezetimibe

Rovista EZ combines rosuvastatin with ezetimibe 10 mg, which lowers the cholesterol absorbed from the gut, in three strengths, 5mg+10mg, 10mg+10mg and 20mg+10mg (DRAP reg. 073716, DRAP reg. 073718, DRAP reg. 073717).

Getz’s Pakistani leaflet for Rovista EZ gives it, with diet, for primary hypercholesterolaemia in people not controlled on rosuvastatin or ezetimibe alone, or already taking both, and for homozygous familial hypercholesterolaemia. It says the combination is not for first-line use.
Must not take Rovista EZ, according to its own leaflet: allergy to rosuvastatin or ezetimibe; acute liver failure or decompensated cirrhosis; pregnancy, breastfeeding, or women who could become pregnant and are not using contraception; muscle disease (myopathy); taking ciclosporin, fenofibrate or fusidic acid; or gallbladder disease.
The Rovista EZ leaflet does not recommend it for children and adolescents under 18.
Don’t switch between Rovista and Rovista EZ, or between strengths, without your doctor: they are different medicines and doses.

Checking your pack is genuine

As of 23 October 2026, a search of DRAP’s website found no alert, recall or rapid alert naming Rovista.

Check that the batch number on the carton matches the batch number on the blister inside, and that the pack is sealed.

We buy only from authorised distributors, and check the batch and expiry on every item before it is packed.

Information as of 23 October 2026. DRAP publishes new alerts on dra.gov.pk.

Returns and replacements

Medicines and supplements can’t be returned once they have left our pharmacy.

Returned medicine can never go back into saleable stock. That is a safety rule, not a commercial one.
If an item arrives damaged or wrong, tell us on WhatsApp within 24 hours and we replace it. That is us fixing our mistake, not a return.
Anything that arrives expired or within a month of expiry we replace or refund, your choice, with no time limit.

Our returns policy

Frequently asked questions

What is Rovista tablet 5mg used for?

Rovista contains rosuvastatin, a statin. Getz’s Pakistani leaflet lists high cholesterol and mixed dyslipidaemia, inherited high cholesterol, high triglycerides and slowing the progression of atherosclerosis, each with diet, and preventing major cardiovascular events in people at high risk. Which strength suits you is your doctor’s decision.

Can Rovista cause muscle pain?

It can. Getz’s leaflet lists muscle pain as a common side effect, and muscle disease and serious muscle breakdown as rare ones. The UK label asks patients to report unexplained muscle pain, weakness or cramps immediately, especially with fever or feeling unwell.

When should I take Rovista Tablet?

Once a day, at any time of day, with or without food, according to Getz’s leaflet. Take aluminium and magnesium antacids at least 2 hours after it.

How quickly does Rovista Tablet work?

Getz’s leaflet says cholesterol levels should be checked within 2 to 4 weeks of starting, and the dose adjusted if needed.

Do you need a prescription to buy Rovista tablet 5mg?

Yes. Getz’s Pakistani leaflets for Rovista and Rovista EZ say “To be sold on prescription of a registered medical practitioner only.”, so we dispense it on prescription.

What is Rovista EZ used for?

Rovista EZ combines rosuvastatin with ezetimibe. Getz’s leaflet gives it, with diet, for high cholesterol in people not controlled on rosuvastatin or ezetimibe alone or already taking both, and for homozygous familial hypercholesterolaemia; it is not for first-line use.

Questions about Rovista Tablet 5mg, 10mg and 20mg (Rosuvastatin)?

Send your question on WhatsApp and a pharmacist will come back to you.

WhatsApp Order Call 0316 5534828

Written by the ePharmacyy pharmacy team.

Last checked against the sources below on 23 October 2026

DRAP registration

Rovista Tablet 10mg (044044), Getz Pharma (Pvt) Ltd. DRAP’s registry shows: Provisionally Active, “Approved / Verified”.
Rovista Tablet 5mg (044043), Getz Pharma (Pvt) Ltd. DRAP’s registry shows: Provisionally Active, “Partially Verified”.
Rovista Tablets 20mg (044045), Getz Pharma (Pvt) Ltd. DRAP’s registry shows: Provisionally Active, “Approved / Verified”.
Rovista EZ 5mg+10mg Tablet (073716), Getz Pharma (Pvt) Ltd. DRAP’s registry shows: Provisionally Active, “Partially Verified”.
Rovista EZ 10mg+10mg Tablet (073718), Getz Pharma (Pvt) Ltd. DRAP’s registry shows: Provisionally Active, “Partially Verified”.
Rovista EZ 20mg+10mg Tablet (073717), Getz Pharma (Pvt) Ltd. DRAP’s registry shows: Provisionally Active, “Partially Verified”.

DRAP publishes no definition of this verification flag, so we can’t tell you what it means. We searched DRAP’s website for “Rovista”, “rosuvastatin” and “statin” on 23 October 2026 and found no alert naming Rovista; the statin results included DRAP’s 2024 safety alert on myasthenia gravis with statins, cited below. When we tested it, the search did not find a word that appears only inside an alert’s attached PDF, so an alert that names a product only in its PDF may not show up. DRAP describes its registered products index as a provisional list that “cannot be used as a reference for any purpose”. Checked against the registry on 23 October 2026.